NMPA Approval

Brimonidine Tartrate and Timolol Maleate Eye Drops

Approval Number

国药准字H20243928

Company艾尔健康眼药（辽宁）有限公司

Registration Date

June 4, 2024

Drug Information

Generic Name

溴莫尼定噻吗洛尔滴眼液

Dosage Form

眼用制剂

Strength

5ml: 酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg（以C₁₃H₂₄N₄O₃S计）

Drug Type

化学药品

Registration Date

June 4, 2024

Company Information

Applicant Company

Company Name艾尔健康眼药（辽宁）有限公司

Company Address

辽宁省沈阳市沈北新区蒲南路158号

Manufacturing Company

Company Name原研药港生物制药（沈阳）股份有限公司

Company Address

沈阳市沈北新区辉山经济开发区沈北路176号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

溴莫尼定噻吗洛尔滴眼液 - NMPA 批准文号 | MedPath